WCLC Updates in Small Cell Lung Cancer
Panelists provide first impressions on recent clinical trials in the treatment of small cell lung cancer and comment on the safety and efficacy of study treatments.
EP: 1.WCLC Updates in KRAS and Rare EGFR-Mutated NSCLC
EP: 2.WCLC Updates on the Emergence of ADCs in NSCLC
EP: 3.WCLC Updates in Immunotherapy for NSCLC
EP: 4.WCLC Updates in Neoadjuvant Therapy for NSCLC
EP: 5.WCLC Updates in Locally Advanced NSCLC
Now Viewing
EP: 6.WCLC Updates in Small Cell Lung Cancer
Data from the following clinical trials are discussed:
- P15.01 - AMG 757, a Half-life Extended Bispecific T-Cell Engager (HLE BiTE® Immune Therapy) Targeting DLL3, for the Treatment of Small Cell Lung Cancer
- OA11.04 - Lurbinectedin With Irinotecan in Relapsed Small Cell Lung Cancer. Results From the Expansion Stage of a Phase I/II Trial
Related Videos
Related Content
